1073 Projecten
  • Missies
  • Soort onderzoek
  • Sector
  • Doel
  • Roadmaps
  • Sleuteltechnologieën
  • Jaar
Using nanoparticles to repair genes in blood stem cells

Using nanoparticles to repair genes in blood stem cells

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • (Bio)pharma
NANOCAST 1 and 2, in which Erasmus MC, LUMC and Harbour Antibodies join forces, aims to develop an efficient delivery method for the systemic administration of CRISPR genome editing components to blood stem cells
Targeting blood vessels to treat dementia

Targeting blood vessels to treat dementia

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission IV: Quality of life for people with dementia
  • Fundamental
  • (Bio)pharma
Novel derivatives of Thalidomide complemented with ultrasound imaging technologies to treat dementia
Improving upon conventional chest radiography diagnostics

Improving upon conventional chest radiography diagnostics

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • Care
Improving on routine chest radiography; AI meets ULDCT to boost healthcare quality and access

Screening of drug efficacy utilizing human atherosclerotic data

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission III: Participating with a disease or disability
  • Fundamental
  • Industrial
Our data point to a novel categorization of atherosclerotic human plaques that will be extremely relevant for patient stratification in drug studies. Five plaque types were discovered that reveal different underlying biology and expression of drug responsive genes.